The future of regenerative medicine: Urinary system

Tissue Engineering - Part B: Reviews

Volumn 18, Issue 3, 2012, Pages 218-224

  Ludlow, John W ^a   Kelley, Russell W ^a   Bertram, Timothy A ^a  

^a Tengion Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL-BASED; CLINICAL MANAGEMENT; MODERN MEDICINE; REGENERATIVE MEDICINE; URINARY SYSTEM;

ENGINEERING; INDUSTRIAL ENGINEERING;

TISSUE;

BLADDER CANCER; BLADDER CONTRACTION; BLADDER DYSFUNCTION; CANCER THERAPY; CELL POPULATION; CELL REGENERATION; CELL RENEWAL; COMORBIDITY; CYSTECTOMY; ERYTHROPOIESIS; HUMAN; HYDRONEPHROSIS; KIDNEY CELL; KIDNEY FAILURE; MEDICAL PRACTICE; MORTALITY; NEPHRON; NEUROGENIC BLADDER; PRIORITY JOURNAL; PROSTATE CANCER; REGENERATIVE MEDICINE; RENAL REPLACEMENT THERAPY; REVIEW; STEM CELL; TISSUE INJURY; TISSUE REGENERATION; TISSUE REPAIR; URINARY TRACT; URINE INCONTINENCE; URINE RETENTION; VASCULARIZATION;

ANIMALS; HUMANS; REGENERATION; REGENERATIVE MEDICINE; URINARY TRACT; UROLOGIC DISEASES;

EID: 84861801348     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2011.0551     Document Type: Review

References (53)

1. Lysaght, M.J., Vonesh, E.F., Gotch, F., Ibels, L., Keen, M., Lindholm, B., Nolph, K.D., Pollock, C.A., Prowant, B., and Farrell, P.C. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 37, 598, 1991.
2. Oberbauer, R., Kreis, H., Johnson, R.W., Mota, A., Claesson, K., Ruiz, J.C., Wilczek, H., Jamieson, N., Henriques, A.C., Paczek, L., Chapman, J., and Burke, J.T. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study. Transplantation 76, 364, 2003.
3. Khoury, J.M., Timmons, S.L., Corbel, L., and Webster, G.D. Complications of enterocystoplasty. Urology 40, 9, 1992.
4. Basu, J., and Ludlow, J.W. Tissue engineering of solid and tubular organs-an industry perspective. In: Winslet-Gendebien, S., ed. Advances in Regenerative Medicine. Rijeka, Croatia: InTech Publishing, 2011, pp.235-260.
5. Basu, J., and Ludlow, J.W. Platform technologies for tubular organ regeneration. Trends Biotechnol 28, 526, 2010.
6. Kumar, A., Godwin, J.W., Gates, P.B., Garza-Garcia, A.A., and Brockes, J.P. Molecular basis for the nerve dependence of limb regeneration in an adult vertebrate. Science 318, 772, 2007.
7. Stappenbeck, T.S., and Miyoshi, H. The role of stromal stem cells in tissue regeneration and wound repair. Science 324, 1666, 2009.
8. Atala, A., Bauer, S.B., Soker, S., Yoo, J.J., and Retik, A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367, 1241, 2006.
9. Jayo, M.J., Jain, D., Wagner, B.J., and Bertram, T.A. Early cellular and stromal responses in the regeneration of a functional mammalian bladder. J Urol 180, 392, 2008.
10. Kelley, R., Werdin, E.S., Bruce, A.T., Choudhury, S., Wallace, S.M., Ilagan, R.M., Cox, B.R., Tatsumi-Ficht, P., Rivera, E.A., Spencer, T., Scott Rapoport, H., Wagner, B.J., Guthrie, K., Jayo, M.J., Bertram, T.A., and Presnell, S.C. Tubular cellenriched subpopulation of primary renal cells improves survival and augments kidney function in rodent model of chronic kidney disease. Am J Physiol Renal Physiol 299, F1026, 2010.
11. Goumans, M.J., Zwijsen, A., van Rooijen, M.A., Huylebroeck, D., Roelen, B.A., and Mummery, C.L. Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice. Development 126, 3473, 1999.
12. Poole, T.J., Finkelstein, E.B., and Cox, C.M. The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev Dyn 220, 1, 2001.
13. Buschmann, I., Heil, M., Jost, M., and Schaper, W. Influence of inflammatory cytokines on arteriogenesis. Microcirculation 10, 371, 2003.
14. Dressler, G.R. Advances in early kidney specification, development and patterning. Development 136, 3863, 2009.
15. Cheng, H.T., Kim, M., Valerius, M.T., Surendran, K., Schuster-Gossler, K., Gossler, A., McMahon, A.P., and Kopan, R. Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. Development 134, 801, 2007.
16. Merkel, C.E., Karner, C.M., and Carroll, T.J. Molecular regulation of kidney development: is the answer blowing in the Wnt? Pediatr Nephrol 22, 1825, 2007.
17. Kreidberg, J.A., Sariola, H., Loring, J.M., Maeda, M., Pelletier, J., Housman, D., and Jaenisch, R. WT-1 is required for early kidney development. Cell 74, 679, 1993.
18. Carroll, T.J., Park, J.S., Hayashi, S., Majumdar, A., and McMahon, A.P. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell 9, 283, 2005.
19. Stark, K., Vainio, S., Vassileva, G., and McMahon, A.P. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372, 679, 1994.
20. Badylak, S.F. Regenerative medicine and developmental biology: the role of the extracellular matrix. Anat Rec B New Anat 287, 36, 2005.
21. Burch, P.A., Croghan, G.A., Gastineau, D.A., Jones, L.A., Kaur, J.S., Kylstra, J.W., Richardson, R.L., Valone, F.H., and Vuk-Pavlovic, S. Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial. Prostate 60, 197, 2004.
22. Jayo, M.J., Jain, D., Ludlow, J.W., Payne, R., Wagner, B.J., McLorie, G., and Bertram, T.A. Long-term durability, tissue regeneration and neo-organ growth during skeletal maturation with a neo-bladder augmentation construct. Regen Med 3, 671, 2008.
23. Bertram, T.A., Christ, G.J., Aboushwareb, T., Wagner, B.J., Jain, D., Ludlow, J.W., Payne, R., Jarapu, Y., Turner, C., and Jayo, M.J. Total regenerated urinary bladders are structurally and pharmacologically similar to native canine bladder tissue. J Urol 179, 76, 2008.
24. Bertram, T.A., Christ, G.J., Andersson, K.E., Aboushwareb, T., Fuellhase, C., Solex, R., Wagner, B.J., Jain, D., Ludlow, J.W., Payne, R., and Jayo, M.J. Pharmacologic response of regenerated bladders in a preclinical model. FASEB J 23, 291, 2009.
25. Yoo, J.J., Olson, J., Atala, A., and Kim, B. Regenerative medicine strategies for treating neurogenic bladder. In Neurol J 15, 109, 2011.
26. Benarroch, E.E. Neurol control of the bladder: recent advances and neurologic implications. Neurology 75, 1839, 2010.
27. Sexton, C.C., Notte, S.M., Maroulis, C., Dmochowski, R.R., Cardozo, L., Subramanian, D., and Coyne, K.S. Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature. Int J Clin Pract 65, 567, 2011.
28. Castellan, M., Gosalbez, R., Perez-Brayfield, M., Healey, P., McDonald, R., Labbie, A., and Lendvay, T. Tumor in bladder reservoir after gastrocystoplasty. J Urol 178, 1771, 2007.
29. Wu, X.R. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer 5, 713, 2005.
30. Madeb, R., Golijanin, D., Knopf, J., and Messing, E.M. Current state of screening for bladder cancer. Expert Rev Anticancer Ther 7, 981, 2007.
31. Konety, B.R., Joyce, G.F., and Wise, M. Bladder and upper tract urothelial cancer. J Urol 177, 1636, 2007.
32. Daneshmand, S., and Bartsch, G. Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer. Expert Rev Anticancer Ther 11, 941, 2011.
33. Cross, W.R., Eardley, I., Leese, H.J., and Southgate, J. A biomimetic tissue from cultured normal human urothelial cells: analysis of physiological function. Am J Physiol Renal Physiol 289, F459, 2005.
34. Fraser, M., Thomas, D.F., Pitt, E., Harnden, P., Trejdosiewicz, L.K., and Southgate, J. A surgical model of composite cystoplasty with cultured urothelial cells: a controlled study of gross outcome and urothelial phenotype. BJU Int 93, 609, 2004.
35. Scriven, S.D., Trejdosiewicz, L.K., Thomas, D.F., and Southgate, J. Urothelial cell transplantation using biodegradable synthetic scaffolds. J Mater Sci Mater Med 12, 991, 2001.
36. Southgate, J., Hutton, K.A., Thomas, D.F., and Trejdosiewicz, L.K. Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab Invest 71, 583, 1994.
37. Turner, A., Subramanian, R., Thomas, D.F., Hinley, J., Abbas, S.K., Stahlschmidt, J., and Southgate, J. Transplantation of autologous differentiated urothelium in an experimental model of composite cystoplasty. Eur Urol 59, 447, 2011.
38. Turner, A.M., Subramaniam, R., Thomas, D.F., and Southgate, J. Generation of a functional, differentiated porcine urothelial tissue in vitro. Eur Urol 54, 1423, 2008.
39. Oberpenning, F., Meng, J., Yoo, J.J., and Atala, A. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol 17, 149, 1999.
40. De Filippo, R.E., Bertram, T.A., Jayo, M.J., and Seltzer, E. Adaptive regulation of regenerated bladder size after implantation with Tengion Neo-Bladder Augment: Early clinical outcomes and preclinical evidence. J Urol 181, 267, 2009.
41. Seltzer, E., Tillinger, M., Jayo, M.J., and Bertram, T.A. Role of biomechanical stimulation (cycling) in neo-bladder regeneration-translational basis for clinical outcomes. J Urol 181, 282, 2009.
42. Bertram, T.A., Christ, G.J., Wagner, B.J., Jain, D., Aboushwareb, T., Ludlow, J.W., Payne, R., Jarapu, Y., Turner, C., and Jayo, M.J. Total urinary bladder regeneration with restoration of native structure and pharmacological response. FASEB J 22, 581, 2008.
43. Genheimer, C., Guthrie, K., Shokes, J.E., Bruce, A.T., Quinlan, S.F., Sangha, N., Ilagan, R.M., Basu, J., Burnette, T., and Ludlow, J.W. Increased sensitivity for cancerous urothelial cell detection within a heterogeneous population of bladder smooth muscle cells using a two-step MACS/qRT-PCR approach. Appl Immunohistochem Mol Morphol 19, 184, 2011.
44. Basu, J., Guthrie, K., Ilagan, R., Sangha, N., Genheimer, C., Quinlan, S., Payne, R., Rapoport, S., Knight, T., Wagner, B.J., Rivera, E., Jayo, M.J., Jain, D., Bertram, T.A., and Ludlow, J.W. Functional de novo Neo-Urinary Conduit from porcine peripheral blood and adipose-derived smooth muscle cells. Presented at the 7th Annual Meeting of the International Society for Stem Cell Research, Barcelona, Spain, 2009.
45. Orlando, G., Baptista, P., Birchall, M., De Coppi, P., Farney, A., Guimaraes-Souza, N.K., Opara, E., Rogers, J., Seliktar, D., Shapira-Schweitzer, K., Stratta, R.J., Atala, A., Wood, K.J., and Soker, S. Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transplant Int 24, 223, 2011.
46. Lin, F., Moran, A., and Igarashi, P. Intrarenal cells, not bone marrow-derived cells, are the major source for regeneration in postischemic kidney. J Clin Invest 115, 1756, 2005.
47. Humphreys, B.D., Valerius, M.T., Kobayashi, A., Mugford, J.W., Soeung, S., Duffield, J.S., McMahon, A.P., and Bonventre, J.V. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2, 284, 2008.
48. Hopkins, C., Li, J., Rae, F., and Little, M.H. Stem cell options for kidney disease. J Pathol 217, 265, 2009.
49. Little, M.H., and Bertram, J.F. Is there such a thing as a renal stem cell? J Am Soc Nephrol 20, 2112, 2009.
50. Little, M.H., and Rae, F.K. Review article: Potential cellular therapies for renal disease: can we translate results from animal studies to the human condition? Nephrology (Carlton) 14, 544, 2009.
51. Benigni, A., Morigi, M., and Remuzzi, G. Kidney regeneration. Lancet 375, 1310, 2010.
52. Hendry, C., Rumballe, B., Moritz, K., and Little, M. Defining and redefining the nephron progenitor population. Pediatr Nephrol 26, 1395, 2011.
53. Diep, C.Q., Ma, D., Deo, R.C., Holm, T.M., Naylor, R.W., Arora, N., Wingert, R.A., Bollig, F., Djordjevic, G., Lichman, B., Zhu, H., Ikenaga, T., Ono, F., Englert, C., Cowan, C.A., Hukriede, N.A., Handin, R.I., and Davidson, A.J. Identification of adult nephron progenitors capable of kidney regeneration in zebrafish. Nature 470, 95, 2011.